Paloma Partners Management Co Makes New Investment in GE HealthCare Technologies Inc. $GEHC

Key Points

• Paloma Partners Management Co has made a new investment of approximately $299,000 in GE HealthCare Technologies Inc., acquiring 3,703 shares during the first quarter.
• Several large institutional investors have recently increased their stakes in the company, with a notable 49.9% stake growth by JPMorgan Chase & Co.
• Analysts have shown positive sentiment toward GE HealthCare, with multiple upgrades including a shift from "hold" to "buy" and a consensus target price of $88.55 for the stock.

Paloma Partners Management Co bought a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,703 shares of the company's stock, valued at approximately $299,000.

Other hedge funds have also recently bought and sold shares of the company. N.E.W. Advisory Services LLC acquired a new stake in GE HealthCare Technologies during the first quarter worth approximately $25,000. Bogart Wealth LLC boosted its position in GE HealthCare Technologies by 260.0% during the first quarter. Bogart Wealth LLC now owns 342 shares of the company's stock worth $28,000 after acquiring an additional 247 shares during the last quarter. Stonebridge Financial Group LLC boosted its position in GE HealthCare Technologies by 165.7% during the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock worth $29,000 after acquiring an additional 222 shares during the last quarter. Accredited Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies in the 4th quarter valued at $30,000. Finally, Ameriflex Group Inc. purchased a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at $31,000. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Stock Up 2.2%

GE HealthCare Technologies stock traded up $1.61 during trading on Friday, reaching $75.73. 3,009,491 shares of the company's stock were exchanged, compared to its average volume of 2,651,304. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16. The firm has a market cap of $34.58 billion, a price-to-earnings ratio of 15.52, a PEG ratio of 2.83 and a beta of 1.13. The company's 50-day moving average is $74.28 and its two-hundred day moving average is $74.14.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping analysts' consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The firm had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. During the same quarter in the previous year, the business posted $1.00 EPS. The firm's revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 25th were issued a $0.035 dividend. The ex-dividend date was Friday, July 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies's payout ratio is currently 2.87%.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. BTIG Research reissued a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Morgan Stanley lowered their price objective on shares of GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating for the company in a research note on Thursday, July 31st. Zacks Research raised shares of GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research note on Thursday, August 28th. Wall Street Zen raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating in a research note on Saturday, May 31st. Finally, Citigroup boosted their price objective on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the company a "buy" rating in a research note on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $88.55.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.